A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 133 (4) , 500-508
- https://doi.org/10.1016/s0022-3476(98)70057-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected ChildrenNew England Journal of Medicine, 1997
- Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trialThe Lancet, 1997
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterNew England Journal of Medicine, 1995
- Assessment of the Effects of Instrumentation, Monoclonal Antibody, and Fluorochrome on Flow Cytometric Immunophenotyping: A Report Based on 2 Years of the NIAID DAIDS Flow Cytometry Quality Assessment ProgramClinical Immunology and Immunopathology, 1993
- Development of normalized curves for the international growth reference: historical and technical considerationsThe American Journal of Clinical Nutrition, 1987
- Combining dependent tests with incomplete repeated measurementsBiometrika, 1985
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- Incremental growth chartsThe American Journal of Clinical Nutrition, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958